AndreaBozzo/ceres-open-data-index huggingface dataset:
Data Quality Plans: Experience from HUD’S HMIS

Active planning for data quality has beneficial results. The federally funded Department of Housing and Urban Development’s (HUD's) Homeless Management Information System (HMIS) requires the development of data quality plans.

States invest significant time and resources collecting and organizing data and, as with any investment, should periodically review and evaluate their efforts. Key discussion points are the elements of a data quality plan as well as the plan's use and value over time in assessing and improving data quality.

This webinar's presenters include Mike Lindsay, senior technical specialist at ICF International and long-time HUD consulting partner, and Gerry Leslie, project director, Michigan Coalition Against Homelessness. Mike will discuss the use of data quality plans associated with HMIS with additional input from Michigan staff who use Michigan’s Statewide HMIS (MSHMIS). An important goal of the MSHMIS Project is to inform both local and statewide public policy about the extent and nature of homelessness.

Metadata-only record linking to the original dataset. Open original dataset below.
Seattle: Drug-Related Emergency Department Visits, 2004-2011 - All Alcohol

Excel file with estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011 for emergency department visits involving alcohol in the Seattle metropolitan area.  For adults aged 21 and older, the alcohol was found in combination with other drugs. For patients under the age of 21, the visit may involve alcohol alone or in combination with other drugs.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Compound 530210: Trimethylsilyl [(trimethylsilyl)oxy](4-[(trimethylsilyl)oxy]phenyl)acetate

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-trimethylsilyloxy-2-(4-trimethylsilyloxyphenyl)acetate. Molecular Formula: C17H32O4Si3. Molecular Weight: 384.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Antitumor effect of lysine-isopeptides

Isopeptides (ε-peptides) of lysine, with a given Mw and low polydispersity (10–400 units), were synthesized to study the relationship between their chemical structure and biological effect. The designed compounds were of high purity, low polydispersity and high stereochemical purity. The effect of the compounds was tested on a human erythroleukemia cell line (K-562) and on four transplantable mouse tumors (L1210 lymphoid leukemia, P38 macrophage derived tumor, Ehrlich ascites carcinoma, Lewis lung tumor /LLT/). In case of the L1210 and P388 tumors and the Ehrlich carcinoma, survival of the animals was used as an indicator of the effect. In case of the Lewis lung tumor, the number and size of metastases in the lung and/or liver of treated and untreated mice were used as indicators. The polymers of polymerisation degree 80–120 (Mw 10.2–15.4 KD) showed the strongest antiproliferative effect both on K562 cells and the tumors growing in vivo. This effect was manifest with a significantly higher survival rate as compared to the control (L1210, P38, Ehrlich ascites), furthermore, by a decrease in the number and size of liver and lung metastases (LLT).
Uniform Facility Data Set (UFDS): 1999 Data on Substance Abuse Treatment Facilities

This report presents results from the 1999 Uniform Facility Data Set (UFDS), an annual survey of facilities providing substance abuse treatment. Conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), the UFDS is designed to collect data on the location, characteristics, and use of alcoholism and drug abuse treatment facilities and services throughout the 50 states, the District of Columbia, and other U.S. jurisdictions.
Program Instruction (PI-13-03)

This Program Instruction (PI) provides instruction to Tribes on the June 30, 2013 Submission of the Annual Progress and Services Report (APSR) required under Title IV-B of the Social Security Act (the Act) for the Stephanie Tubbs Jones Child Welfare Services and Promoting Safe and Stable Families (PSSF) Programs, and the Chafee Foster Care Independence Program (CFCIP), including the Education and Training Vouchers (ETV) program; submission of the CFS-101, Part I, Annual Budget Request; Part II, Annual Summary of Child and Family Services; and Part III, Annual Expenditures for Title IV-B, Subparts 1 and 2.

PI-13-03 (PDF)

Fiscal Year 2013 Allotment Title IV-B Subpart 1 - Stephanie Tubbs Jones Child Welfare
Services
Fiscal Year 2013 Allotment Title IV-B Subpart 2 - Promoting Safe and Stable Families
Fiscal Year 2013 Allotment Title IV-E - Chafee Foster Care Independence Program
Fiscal Year 2013 Allotment Title IV-E - Educational Training Vouchers

CFS-101 Part I: Annual Budget Request for Title IV-B, Subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Program Instructions
CFS-101 Part I: Annual Budget Request for Title IV-B, Subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Program Form 
CFS-101, Part II: Annual Summary of Child and Family Services Instructions
CFS-101, Part II: Annual Summary of Child and Family Services Form 
CFS-101, Part III: Annual Expenditures for Title IV-B, Subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Instructions
CFS-101, Part III: Annual Expenditures for Title IV-B, Subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Form

Children’s Bureau Regional Program Managers

Certification of Tribal Population under Age 21

Training Plan Template

Metadata-only record linking to the original dataset. Open original dataset below.
Table 8. Nonmedical Use of Pain Relievers in the Past Year among Persons Aged 12 or Older, by State and Substate Regions: Percentages, Annual Averages Based on 2008, 2009, and 2010 NSDUHs

This table presents the 2008 to 2010 National Survey on Drug Use and Health (NSDUH) estimates of past year nonmedical use of pain relievers by those aged 12 or older by State and substate regions.
Vaccination Coverage among Adolescents (13-17 Years)

Vaccination Coverage among Adolescents (13-17 Years)

• Data on adolescent vaccination coverage and selected sociodemographic characteristics by State, HHS Region, and the United States from the National Immunization Survey-Teen (NIS-Teen).

• Additional information available at https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/index.html
Patent AT-E400014-T1: [Translated] METHOD FOR PREAUTHORIZING HANDOVERS BETWEEN ACCESS ROUTERS IN COMMUNICATION NETWORKS

An apparatus and method is provided for facilitating the handoff of a mobile terminal from a first access device in a first network to a second access device in a second network. Prior to performing a handoff operation, the first access device inquires as to whether the mobile terminal is authorized to be handed off to the second access device and, in response thereto, completes the handoff. If the mobile terminal is not authorized to be handed off to the second access device, the handoff operation is inhibited, preferably without using any radio frequency resources of the second access device.
Health Equity Impact Assessment Program

This dataset includes information extracted from Health Equity Impact Assessments (HEIA) and related documents submitted to the Department with Certificate of Need (CON) applications. It includes general project information, stakeholder engagement details, meaningful engagement themes, and mitigation strategies. It also contains the Health Equity Impact Assessment evaluation date and conclusion. The de-identified data file does not contain data that is protected health information (PHI) under Health Insurance Portability and Accountability Act (HIPAA). All Health Equity Impact Assessments and related documents are available for download.

For more information visit: <a href=https://www.health.ny.gov/community/health_equity/impact_assessment>health.ny.gov/community/health_equity/impact_assessment</a>
Patent AT-E401661-T1: [Translated] SHIELDED ENCLOSURE VACUUM INTERRUPTER

A shielded encapsulated vacuum interrupter with a ceramic vacuum chamber and opposing conductive end caps is provided. One end cap is electrically connected to a fixed contact, while an opposing end cap is connected to a moving contact. The moving contact is actuatable with the fixed contact for opening or closing an electric circuit. A floating shield inside the vacuum chamber connected to the vacuum chamber ceramic wall and spaced from the fixed and moving contacts is isolated and has a floating voltage potential. A portion of the vacuum chamber exterior ceramic wall is coated with a semi-conductive material and conductive voltage screens enclose a portion of the vacuum chamber exterior and are electrically connected to each conductive end cap of the vacuum chamber. The chamber and connected screens are encapsulated in a molded dielectric housing.
A criterion audit of women's awareness of blood transfusion in pregnancy

Background
          In the Confidential Enquiry into Maternal Deaths (CEMD) Report, the very high risk of mortality in women who refuse blood transfusions is highlighted. The objectives were to establish current knowledge about, and views of transfusion in our pregnant population and to establish the level of compliance with the set audit standard.
        
        
          Method
          Questionnaire survey of 228 women, including both high and low risk pregnancies, attending ante-natal clinic between 2–9 May 2000 at the North Staffordshire Maternity Hospital, Stoke on Trent.
        
        
          Results
          The response rate was 100%. Only 43% were aware of the possible need for blood transfusion in pregnancy. If a blood transfusion was required, 92% stated that they would accept a blood transfusion in pregnancy. Four percent stated that they would not accept a transfusion because of religious reasons and risk of infection and the remaining four percent did not declare a reason.
        
        
          Conclusions
          This short survey identified that 57% of women were not aware of the possible need for blood transfusion during pregnancy. There is a need for more information to be shared on this subject with all antenatal women. Women who would refuse a transfusion need to be identified at booking and be referred for counselling and a management plan made for pregnancy, labour and delivery.
Systemic toxicity induced by topical application of the sulfonic acids, perfluorobutane sulfonic acid (PFBS) and perfluoropentane sulfonic acid (PFPeS), in a murine model

Per- and polyfluoroalkyl substances (PFAS) are a large group of synthetic surfactants incorporated into products for their chemical and physical properties. Studies have associated PFAS with adverse health effects. Although there is a high potential for dermal exposure, toxicity studies related to this route of exposure are lacking. The present study evaluated the systemic toxicity following a sub chronic 28- day dermal exposure to PFBS (1.25-5%) or PFPeS (1.25-5%) in a murine model. Elevated levels of both PFAS were detected in the serum and urine, suggesting that absorption is occurring through the dermal route. Additionally, both PFAS induced significantly increased relative liver weight, altered serum chemistries, altered skin and liver histopathology, and significantly decreased relative spleen (PFPeS). Gene expression changes were observed in the liver and skin, of genes involved in fatty acid metabolism, inflammation, and skin integrity. In general, the toxicity was more dramatic for PFPeS compared to PFBS, suggesting that longer chain PFAS may be more toxic.  These findings support PFAS absorption through the skin leading to liver damage and systemic toxicity.
Compound 527205: (1R,4aS,8aR)-1,4a-Dimethyl-7-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene

Chemical compound data from PubChem database. IUPAC Name: 4,8a-dimethyl-6-prop-1-en-2-yl-2,3,4,4a,7,8-hexahydro-1H-naphthalene. Molecular Formula: C15H24. Molecular Weight: 204.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530219: OH-Pro, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 1-trimethylsilyl-5-trimethylsilyloxypyrrolidine-2-carboxylate. Molecular Formula: C14H33NO3Si3. Molecular Weight: 347.67. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
MedGen

MedGen is NCBI's portal to information about conditions and phenotypes related to Medical Genetics. Terms from the NIH Genetic Testing Registry (GTR), UMLS,  HPO, Orphanet, ClinVar and other sources are aggregated into concepts, each of which is assigned a unique identifier and a preferred name and symbol. The core content of the record may include names, identifiers used by other databases, mode of inheritance, clinical features, and map location of the loci affecting the disorder. The concept identifier (CUI) is used to aggregate information about that concept, similar to the way NCBI Gene serves as a gateway to gene-related information.

MedGen provides links to such resources as: Genetic tests registered in the NIH Genetic Testing Registry (GTR), GeneReviews, ClinVar, OMIM, Related genes, Disorders with similar clinical features, Medical and research literature, Practice guidelines, Consumer resources, Ontologies such as HPO and ORDO.

Links to the GTR, GeneReviews, and Practice Guidelines are based on curation by NCBI staff. Other data feeds are automated, but reviewed by NCBI staff and informed by feedback from the community.
Compound 530731: m-Anisic acid, but-3-yn-2-yl ester

Chemical compound data from PubChem database. IUPAC Name: but-3-yn-2-yl 3-methoxybenzoate. Molecular Formula: C12H12O3. Molecular Weight: 204.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399831-T1: [Translated] PHOSPHORUS AND LIGHT EMITTING DEVICE USING THE SAME

There is provided a phosphor emitting light of high brightness and having high weatherability, which has a composition represented by the following general formula:  n (M 1  1-y R y ) a MgM 2  b M 3  c O a+2b+(3/2)c X 2   nwherein M 1  is at least one element selected from the group consisting of Ca, Sr, Ba, Zn and Mn, M 2  is at least one element selected from the group consisting of Si, Ge and Sn, M 3  is at least one element selected from the group consisting of B, Al, Ga and In, X is at least one element selected from the group consisting of F, Cl, Br and I, R is at least one element selected from the group consisting of rare earth elements with Eu being an inevitable element, and y, a, b and c satisfy the following relationships of 0.0001   y   0.3, 7.0   a < 10.0, 3.0   b < 5.0 and 0   c < 1.0.
Engaging Fathers Part 1

This Child Welfare Information Gateway Podcast is available on Apple Podcasts
  
  

, GooglePlay
  
  

, Spotify
  
  

, Stitcher
  
  

, SoundCloud
  
  

, and the Child Welfare Information Gateway
  
  

 website. Subscribe to receive new episodes as they are released.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 530286: Ethyl 2-([(3,4-dichloroanilino)carbonyl]amino)-4-methyl-1,3-thiazole-5-carboxylate

Chemical compound data from PubChem database. IUPAC Name: hexyl 4-methylpentanoate. Molecular Formula: C12H24O2. Molecular Weight: 200.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529264: [3-(Bromomethyl)oxetan-3-yl]methanol

Chemical compound data from PubChem database. IUPAC Name: [3-(bromomethyl)oxetan-3-yl]methanol. Molecular Formula: C5H9BrO2. Molecular Weight: 181.03. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Elk Creek Seismic Waveforms 2012 (Part 2 of 20)

Coal bursts (damaging seismic events in underground coal mines) pose a substantial threat to operations and mine workers. The underground coal mines in Colorado’s North Fork Valley (NFV) have experienced many coal bursts, often with distinct characteristics from those of other US coal mining regions. To better understand these events and manage their associated risks, the National Institute for Occupational Safety and Health undertook a long-term monitoring campaign at the Elk Creek Mine in the NFV. The monitoring efforts included a seismic network composed of both surface and underground sensors, borehole pressure cells (BPCs), instrumented support Cans, convergence monitors, ground condition surveys, and several other data sources. This dataset consists of the event waveform files from the seismic network for the 983,379 events that were detected during the monitoring campaign. The waveforms are stored in HDF5 files that are broken up by week. Within the HDF5 files, the data are organized by station id, event time, and channel. The amplitudes are velocity in meters/second.
 
This is download 29 of 48 and corresponds to the time range between February 20, 2012, and March 5, 2012.
2014 CMHS Uniform Reporting System (URS) Table for American Samoa

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for American Samoa. The URS territories reporting system is collected annually to support the Community Mental Health Services Block Grant program. Territories Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
5.2b Clients in treatment, according to type of care received, by facility operation and primary focus of facility: March 31, 2011. Percent distribution (row percent)

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing clients in treatment, according to type of care received, by facility operation and primary focus of facility in 2011. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Compound 526203: 2,4-Tert-butyl-6-hydroxym ethyl-phenol

Chemical compound data from PubChem database. IUPAC Name: 2,4-ditert-butyl-6-(hydroxymethyl)phenol. Molecular Formula: C15H24O2. Molecular Weight: 236.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529094: 3-methyl-4H-pyrido(1,2-a)pyrimidin-4-one

Chemical compound data from PubChem database. IUPAC Name: 3-methylpyrido[1,2-a]pyrimidin-4-one. Molecular Formula: C9H8N2O. Molecular Weight: 160.17. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400236-T1: [Translated] GUIDE WIRE LOADED STENT FOR DELIVERY THROUGH A CATHETER

A guidewire loaded stent for delivery through a catheter is described herein. The stent delivery assembly can deliver and place a stent within tortuous regions of the body which are accessible to guidewires but inaccessible to stenting catheters. The assembly comprises a guidewire covered in part by a retractable sheath and a radially expandable stent near or at the distal end of the guidewire. The guidewire has a proximal stop for maintaining the position of the stent along the guidewire. The whole assembly is advanced through conventional catheters or it may be used alone. In either case, when the stent is adjacent to a treatment site within the body, the sheath is retracted proximally to expose the stent for radial expansion into contact with the vessel wall.
Diclofenac sodium and misoprostol

Diclofenac Sodium and Misoprostol is a prescription medication combining an NSAID for pain and inflammation relief with a prostaglandin analog to protect the stomach. Available as oral delayed-release tablets in 50mg/0.2mg and 75mg/0.2mg strengths, it's marketed by BluePoint Laboratories under ANDA201089. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E399915-T1: [Translated] PLASTERBOARD WITH INSPECTION OPENING AND CORRESPONDING LOCKING PART

In a plasterboard panel (1), an inspection opening (2) and a related closure element (3), comprising a first plasterboard plate (30) having dimensions substantially corresponding to those of the inspection opening (2) and thickness substantially equal to the thickness of the panel (1), are flared upwards and their respective lower faces (21, 31) have exactly the same shape and dimensions. The inspection opening (2) has segments (22) of inner peripheral edge (23) inclined by a predetermined minimum angle ( alpha ) relative to the perpendicular to the panel (1), for the abutment of corresponding, counter-shaped portions (32) of outer peripheral edge (33) of the closure element (3) inclined by the same angle ( alpha ), in order stably to support the element (3) in the position of insertion in the inspection opening (2) with its own lower face (31) substantially coplanar to a lower face (10) of the panel (1). Preferably, the segments (22) of the inner peripheral edge (23) are in mutual contact and together involve the whole inner peripheral edge (23), the portions (32) of the outer peripheral edge (33) being, correspondingly, also in mutual contact and together involving the whole outer peripheral edge (33) of the closure element (3). <IMAGE>
Diabetes State Burden Toolkit - Health Burden

This section of the Burden Toolkit reports the health burden of diabetes in your state and consists of diabetes prevalence, diabetes incidence, and diabetes-associated conditions. The statistics for diabetes-associated conditions are based on self-reported data, hospitalization data, and Medicare data. For each condition, the toolkit reports the rate of the condition among people with diabetes and the number of cases attributable to diabetes.

Data sources: 2020-2021 Behavioral Risk Factor Surveillance System (BRFSS). Agency for Healthcare Research and Quality (AHRQ), Healthcare Cost and Utilization Project (HCUP), State Inpatient Databases (SID). 2021 Medicare Master Beneficiary Summary (MBS) File. For detail, see the Technical Report: https://www.cdc.gov/diabetes/burden-toolkit/docs/technical_documentation.pdf